비교리스트

 카트 문의
시장보고서
상품코드
1389608

세계 혈관 폐쇄 장치 시장 규모 및 예측 - 지역별 점유율, 동향, 성장 기회 분석 : 제품 유형별, 액세스별, 처치별, 최종 사용자별, 지역별

Vascular Closure Device Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis By Product Type, Access, Procedure, and End User, and Geography
발행일: | 리서치사: The Insight Partners | 페이지 정보: 영문 197 Pages | 배송안내 : 즉시배송

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 혈관 폐쇄 장치 시장은 2022년 16억 2,000만 달러에서 2030년에는 28억 400만 달러에 이를 것으로 예측됩니다. 이 시장은 2022-2030년간 CAGR 7.1%로 성장할 것으로 추정됩니다.

시장 성장을 가속하는 주요 요인으로는 심혈관 질환의 유병률 증가, 낮은 침습 장치에 대한 수요 급증 등이 있습니다. 그러나 혈관 폐쇄 장치와 관련된 감염 위험은 시장 성장을 방해합니다.

혈관 폐쇄 장치 시장 시장 기회

인도, 중국, 아르헨티나, 브라질, 아랍에미리트(UAE), 남아프리카 등 신흥 국가들은 가처분 소득 증가, 환자 인구 확대, R&D 활동 활성화, 의료 인프라 개선, CVD에 대한 인식 증가, 첨단 국가에 비해 비교적 완만한 지침 등으로 혈관 폐쇄 장치 시장의 기업에게 큰 성장 기회를 제공할 것으로 기대되고 있습니다. 세계경제포럼에 따르면 2022년 현재 러시아, 브라질, 중국, 인도, 남아프리카공화국이 합쳐 세계의 총 의료비의 3분의 1을 차지하고 있습니다. 세계은행에 따르면 2018년부터 2019년까지 인도와 중국의 의료비는 각각 3.01%, 5.35% 증가했습니다. 또한 신흥 시장에서는 지난 10년간 심부전증례가 급증해 심혈관질환 관련 사망자가 많이 나오고 있습니다. 인도 브랜드 에퀴티 재단에 따르면 인도 의료 부문의 수익 중 병원이 차지하는 비율은 70% 정도입니다. 중국에서는 민간 병원의 수가 2022년 36,000개에 달했습니다. 게다가 사립병원은 이 나라의 병원 총수의 최대 57%를 차지하고 있습니다. 신흥국시장의 수술센터와 병원 수는 의료비 증가와 대상 환자 수 급증으로 증가할 것으로 추정됩니다. 따라서 신흥경제국에서의 의료시설의 발전과 병원수의 급증은 신흥경제국에서 혈관 폐쇄 장치의 인지도와 채용을 촉진하는 것으로 보입니다. 게다가 선진국 시장과 성숙 시장에서는 경쟁이 심해 혈관 폐쇄 장치 제조업체가 신흥국 시장에 주력하게 되어 혈관 폐쇄 장치 프로바이더가 시장에서 중요한 지위를 획득하는 기회가 될 가능성이 높습니다.

혈관 폐쇄 장치 시장을 방해하는 요인

혈관 폐쇄 장치는 수동 압박과 비교하여 감염을 일으키기 쉽습니다. 살서제 혈종은 대퇴 혈관 폐쇄 장치를 사용하는 동안 대퇴 동맥을 제어 할 수없는 경우 외장을 제거한 직후에 발생할 수있는 가장 일반적인 문제 중 하나입니다. 혈관 폐쇄 장치가 고장난 경우, 지혈을 달성하기 위해 절차에 의한 압박을해야합니다. 살서제 혈종은 대퇴 동맥 접근과 관련된 가장 흔한 합병증이며 혈종이 발생한 환자는 정상적인 신체 활동에 심각한 장애를 일으킬 수 있습니다. 그러므로 고강부 혈종은 합병증과 입원기간 연장으로 인한 의료비 증가로 이어질 수 있습니다. 폐쇄 기구의 다른 주목할 만한 합병증으로는 사지의 허혈과 동맥 절개 부위의 말단에서의 허혈이 있습니다. 사지 원위 허혈은 일반적으로 원위 색전 또는 혈전증에 의해 일어날 수 있으며 동맥의 석회화가 심한 부위에서는 금기인 폐쇄 기구의 장착으로 인해 발생할 수 있습니다. 절차에 의한 압박에 비해 사지 허혈 감염은 혈관 폐쇄 장치에서 더 일반적입니다. 따라서 감염 위험은 혈관 폐쇄 장치 시장의 성장을 어느 정도 억제합니다.

혈관 폐쇄 장치 시장 : 지역별 개요

2022년 혈관 폐쇄 장치 세계 시장에서 북미는 가장 큰 점유율을 차지합니다. 이 지역에서는 미국이 혈관 폐쇄 장치 시장에서 가장 큰 점유율을 차지하고 있으며 2022-2030년에 가장 높은 CAGR을 기록할 것으로 예측됩니다. 미국은 2022-2030년에 혈관 폐쇄 장치 시장에서 가장 큰 점유율을 차지할 것으로 추정됩니다. 이 나라는 고도로 발달한 장비와 기구를 이용할 수 있는 헬스케어 부문이 발달하고 있습니다. 이 나라는 심혈관 질환의 유병률이 높습니다. 미국 심장협회에 의한 "Heart Disease and Stroke Statistics-2023 Update"에 따르면 2020년 미국에서 CVD와 관련된 사망의 주요 원인(41.2%)은 관상동맥성 심장 질환(CHD)이며 뇌졸중(17.3%)), 기타 CVD(16.8%), 고혈압(12.9%), 심부전(9.2%), 동맥 질환(2.6%)이 각각 이어집니다. 미국 질병 예방관리센터(CDC)에 따르면 미국에서는 20세 이상 성인 20명 중 1명이 관상동맥 질환을 앓고 있습니다. 또한이 연구는 미국에서 가장 흔한 심장병으로 관상 동맥 질환을 포함합니다. 따라서 CVD와 관상동맥 질환의 유병률이 높아지면 향후 몇 년동안 미국에서 수술 개입 시 혈관 폐쇄 장치의 채용을 촉진할 것으로 보입니다.

미국은 의료 혁신과 헬스케어의 기술 진보의 거점입니다. 낮은 침습 절차와 관련된 기술의 지속적인 발전, 폐쇄 장치 기술 개선, 새로운 폐쇄 장치의 도입은 미국의 혈관 폐쇄 장치 시장의 성장에 기여하고 있습니다. 예를 들어, 2023년 3월, Haemonetics Corporation(미국)은 Vivasure Medical Limited에 3,172만 달러(3,000만 유로)를 투자했습니다. 2023년 3월 Vivasure Medical은 Vivasure PerQseal Closure Device System의 안전성과 효능을 평가하는 미국 피보탈 시험을 시작하기 위한 FDA IDE 승인을 발표했습니다. 2021년 바스케이드 MVP는 심방세동(AF) 절제 후 혈관 폐쇄 장치로 처음으로 FDA에 승인되어 같은 날 퇴원이 가능해졌습니다.

혈관 폐쇄 장치 시장에 관한 보고서 작성시 참조한 주요 1차 및 2차 정보는 세계은행 데이터, 국민보건서비스(NHS), FDA(식품의약품국), EMA(유럽의약품청), WHO(세계 보건기구) 등이 있습니다.

목차

제1장 서론

제2장 주요 요약

  • 주요 인사이트

제3장 조사 방법

  • 조사 범위
  • 2차 조사
  • 1차 조사

제4장 혈관 폐쇄 장치 시장 상황

  • 개관
  • PEST 분석
    • 세계의 PEST 분석

제5장 혈관 폐쇄 장치 시장 - 주요 산업 역학

  • 시장 성장 촉진요인
    • 심혈관질환의 유병률 증가
    • 저침습 장치에 대한 수요의 급증
  • 시장 성장 억제요인
    • 혈관 폐쇄 장치에 대한 감염 위험
  • 시장 기회
    • 신흥경제권의 미개척 가능성
  • 향후의 동향
    • 제조업체에 의한 전략적 활동
  • 영향 분석

제6장 혈관 폐쇄 장치 시장 : 세계 시장 분석

  • 혈관 폐쇄 장치 시장의 수익(2022-2030년)

제7장 혈관 폐쇄 장치 세계 시장 - 제품 유형별 수익과 예측(-2030년)

  • 혈관 폐쇄 장치 시장의 수익 점유율, 제품 유형별(2022년 및 2030년)(%)
  • 액티브
  • 패시브
  • 외부 지혈 장치

제8장 혈관 폐쇄 장치 세계 시장 - 액세스별 수익과 예측(-2030년)

  • 혈관 폐쇄 장치 시장의 수익 점유율, 액세스별(2022년 및 2030년)(%)
  • 대퇴 액세스
  • 요골 액세스

제9장 혈관 폐쇄 장치 세계 시장 - 처치별 수익과 예측(-2030년)

  • 혈관 폐쇄 장치 시장의 수익 점유율, 처치별(2022년 및 2030년)(%)
  • 인터벤셔널 카디올로지
  • 인터벤셔널 라디오로지
  • 혈관내 수술

제10장 혈관 폐쇄 장치 세계 시장 - 최종 사용자별 수익과 예측(-2030년)

  • 혈관 폐쇄 장치 시장의 수익 점유율, 최종 사용자별(2022년 및 2030년)(%)
  • 병원
  • 외래수술센터(ASC)
  • 기타

제11장 혈관 폐쇄 장치 시장 분석 : 지역별

  • 북미
    • 멕시코
  • 유럽
    • 기타 유럽
  • 아시아태평양
    • 기타 아시아태평양
  • 중동 및 아프리카
    • 기타 중동 및 아프리카
  • 중남미
    • 기타 중남미

제12장 혈관 폐쇄 장치 시장 : 업계 정세

  • 혈관 폐쇄 장치 시장에서의 성장 전략
  • 무기적 성장 전략
  • 유기적 성장 전략

제13장 기업 프로파일

  • Cordis Corp
  • Transluminal Technologies LLC
  • Vasorum Ltd
  • Haemonetics Corp
  • Abbott Laboratories
  • Becton Dickinson and Co
  • Cardinal Health Inc
  • ENDOCOR GmbH & CO KG
  • Medtronic Plc
  • Teleflex Inc

제14장 부록

JHS 23.12.15

The global vascular closure device market is expected to reach US$ 2.804 billion in 2030 from US$ 1.620 billion in 2022. The market is estimated to grow with a CAGR of 7.1% from 2022 to 2030.

The key factors driving the market's growth include increasing prevalence of cardiovascular diseases and burgeoning demand for minimally invasive devices. However, risk of infection related to vascular closure devices hinder the market growth.

Market Opportunities of Vascular Closure Device Market

Emerging countries such as India, China, Argentina, Brazil, UAE, and South Africa are expected to offer significant growth opportunities for vascular closure devices market players due to rising disposable incomes, expanding patient population, increasing R&D activities, improving healthcare infrastructure, growing CVD awareness, and relatively lenient guidelines compared to developed countries. According to the World Economic Forum, as of 2022, Russia, Brazil, China, India, and South Africa collectively accounted for a third of total global health spending. As per the World Bank, health spending in India and China increased by 3.01% and 5.35%, respectively, from 2018 to 2019. Also, there has been an upsurge in heart failure cases over the past decade in emerging markets, which has resulted in a large number of cardiovascular disease-related deaths. As per the India Brand Equity Foundation, hospitals contribute to ~70% of the revenue of the healthcare sector in India. In China, the number of private hospitals reached up to 36,000 in 2022. Moreover, the private hospitals account for ~57% of total number of hospitals in the country. The number of surgical centers and hospitals in developing markets is estimated to grow due to rising healthcare spending and a surge in the target patient population. Therefore, the development of healthcare facilities in developing economies along with a surge in a number of hospitals would propel the awareness and adoption of vascular closure devices in emerging economies. Further, vast competition in developed or matured markets encourages vascular closure device manufacturers to focus on developing markets, which is likely to offer growth opportunities for vascular closure device providers to attain a significant position in the market.

Factors Hampering Vascular Closure Device Market

Vascular closure devices are more prone to causing infections as compared to manual compression. Groin hematomas is among the most common problems that can occur just after sheath removal if there is inability to control the femoral artery while using femoral vascular closure devices. In cases of vascular closure device failure, manual compression must be applied to accomplish hemostasis. Groin hematomas are the most common complication with femoral access, and patients who develop a hematoma may be seriously hindered in normal physical activities. Thus, groin hematomas may lead to incremental health costs due to complications and extended length of stay in hospital. Other notable complications of closure devices include limb ischemia and ischemia distal to the arteriotomy site. Distal limb ischemia commonly occurs through distal embolization or thrombosis, and it can be caused due to the placement of a closure device which is contraindicated in heavily calcified areas of arteries. Compared to manual compression, limb ischemia infection is more common in vascular closure devices. Thus, the risk of infection hampers the growth of the vascular closure device market to a certain extent.

Vascular Closure Device Market: Segmental Overview

The vascular closure device market, by product type, is segmented into active approximators, passive approximators, and external hemostatic devices. The passive approximators segment held the largest share of the market in 2022, and it is anticipated to register the highest CAGR in the market during 2022-2030. Passive approximators deploy a plug, sealant, or gel at the arteriotomy site instead of closing it via an active mechanism. Unlike active approximators, passive approximators do not require any additional closure mechanisms, such as sutures or clips, once deployed. Passive approximators typically consist of biodegradable or resorbable components that facilitate the natural clotting process and promote the formation of a stable blood clot at a puncture site.

Based on access, the vascular closure device market has been segmented into femoral access and radial access. The femoral access segment held a larger share of the market in 2022. The radial access segment is expected to register a higher CAGR in the market during 2022-2030. Femoral access involves accessing blood vessels through the femoral artery in the groin area, while radial access involves accessing blood vessels through a radial artery in the wrist. The radial approach has gained popularity in recent years due to its advantages such as reduced risk of complications, including bleeding and hematoma, compared to femoral access.

Based on procedure, the vascular closure device market is segmented into interventional radiology, interventional cardiology, and endovascular surgical. The interventional cardiology segment held the largest share of the market in 2022. However, the interventional radiology segment is expected to register the highest CAGR in the market during 2022-2030. Interventional radiology (IR) is a medical specialty that uses minimally invasive techniques guided by medical imaging to diagnose and treat a wide range of conditions.

Based on end user, the vascular closure device market is segmented into hospitals, ambulatory surgical centers, and others. The hospital segment held the largest share of the market in 2022. The ambulatory surgical centers segment is further expected to register the highest CAGR in the market during 2022-2030. Hospitals are the primary end users of vascular closure devices as they offer a wide range of medical services, including invasive procedures that require vascular access.

Vascular Closure Device Market: Geographical Overview

North America accounted for the largest share of the global vascular closure device market in 2022. In the region, the US held the largest vascular closure device market share and is anticipated to register the highest CAGR during 2022-2030. The US is estimated to hold the largest share of the vascular closure device market during 2022-2030. The country has a well-developed healthcare sector with access to highly advanced equipment and instruments. It reports a high prevalence of cardiovascular diseases. According to the "Heart Disease and Stroke Statistics - 2023 Update" by the American Heart Association, in 2020, coronary heart disease (CHD) was a leading cause (41.2%) of deaths associated with CVDs in the US, followed by stroke (17.3%), other CVD (16.8%), high blood pressure (12.9%), heart failure (9.2%), and artery diseases (2.6%), respectively. As per the US Centers for Disease Control and Prevention (CDC), ~1 in 20 adults in the US, aged 20 and above, have coronary artery disease. The study also mentions coronary artery disease as the most common type of heart disease in the US. Thus, a high prevalence of CVDs and coronary artery disease would propel the adoption of vascular closure devices during surgical interventions in the US in the coming years.

The US is a hub for medical innovations and technological advancements in healthcare. Continuous advancements in technologies associated with minimally invasive procedures, improvements in closure device technologies, and the introduction of novel closure devices contribute to the growth of the vascular closure devices market in the US. For instance, in March 2023, Haemonetics Corporation (US) invested ~US$ 31.72 million (EUR 30 million) in Vivasure Medical Limited. In March 2023, Vivasure Medical announced FDA IDE approval to Initiate a US Pivotal Study evaluating the safety and effectiveness of the Vivasure PerQseal Closure Device System. In 2021, VASCADE MVP was the first and only FDA-approved vascular closure device indicated for use following atrial fibrillation (AF) ablation to allow same-day discharge.

A few of the major primary and secondary sources referred to while preparing the report on the vascular closure device market are the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (World Health Organization).

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the vascular closure device market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global vascular closure device market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the vascular closure device market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Vascular Closure Device Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Global PEST Analysis

5. Vascular Closure Device Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Prevalence of Cardiovascular Diseases
    • 5.1.2 Burgeoning Demand for Minimally Invasive Devices
  • 5.2 Market Restraints
    • 5.2.1 Risk of Infection Related to Vascular Closure Devices
  • 5.3 Market Opportunities
    • 5.3.1 Untapped Potential of Emerging Economies
  • 5.4 Future Trends
    • 5.4.1 Strategic Activities by Manufacturers
  • 5.5 Impact Analysis:

6. Vascular Closure Device Market - Global Market Analysis

  • 6.1 Vascular Closure Device Market Revenue (US$ Mn), 2022 - 2030

7. Global Vascular Closure Device Market - Revenue and Forecast to 2030 - by Product Type

  • 7.1 Overview
  • 7.2 Vascular Closure Device Market Revenue Share, by Product Type 2022 & 2030 (%)
  • 7.3 Active Approximators
    • 7.3.1 Overview
    • 7.3.2 Active Approximators: Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.1 Active Approximators: Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Passive Approximators
    • 7.4.1 Overview
    • 7.4.2 Passive Approximators: Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.4.2.1 Passive Approximators: Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 External hemostatic devices
    • 7.5.1 Overview
    • 7.5.2 External hemostatic devices: Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Vascular Closure Device Market - Revenue and Forecast to 2030 - by Access

  • 8.1 Overview
  • 8.2 Vascular Closure Device Market Revenue Share, by Access 2022 & 2030 (%)
  • 8.3 Femoral Access
    • 8.3.1 Overview
    • 8.3.2 Femoral Access: Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Radial Access
    • 8.4.1 Overview
    • 8.4.2 Radial Access: Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Vascular Closure Device Market - Revenue and Forecast to 2030 - by Procedure

  • 9.1 Overview
  • 9.2 Vascular Closure Device Market Revenue Share, by Procedure 2022 & 2030 (%)
  • 9.3 Interventional Cardiology
    • 9.3.1 Overview
    • 9.3.2 Interventional Cardiology: Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Interventional Radiology
    • 9.4.1 Overview
    • 9.4.2 Interventional Radiology: Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Endovascular Surgical
    • 9.5.1 Overview
    • 9.5.2 Endovascular Surgical: Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)

10. Global Vascular Closure Device Market - Revenue and Forecast to 2030 - by End Users

  • 10.1 Overview
  • 10.2 Vascular Closure Device Market Revenue Share, by End Users 2022 & 2030 (%)
  • 10.3 Hospitals
    • 10.3.1 Overview
    • 10.3.2 Hospitals: Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Ambulatory Surgical Center
    • 10.4.1 Overview
    • 10.4.2 Ambulatory Surgical Center: Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)

11. Vascular Closure Device Market - Geographical Analysis

  • 11.1 North America Vascular Closure Device Market, Revenue And Forecast To 2030
    • 11.1.1 Overview
    • 11.1.2 North America Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
      • 11.1.2.1 North America Vascular Closure Device Market, by Product Type
        • 11.1.2.1.1 North America: Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
        • 11.1.2.1.2 North America: Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
      • 11.1.2.2 North America Vascular Closure Device Market, by Access
      • 11.1.2.3 North America Vascular Closure Device Market, by Procedure
      • 11.1.2.4 North America Vascular Closure Device Market, by End Users
      • 11.1.2.5 North America Vascular Closure Device Market, by Country
      • 11.1.2.6 US
        • 11.1.2.6.1 Overview
        • 11.1.2.6.2 US Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.2.6.3 US Vascular Closure Device Market, by Product Type
        • 11.1.2.6.3.1 US: Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
        • 11.1.2.6.3.2 US: Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
        • 11.1.2.6.4 US Vascular Closure Device Market, by Access
        • 11.1.2.6.5 US Vascular Closure Device Market, by Procedure
        • 11.1.2.6.6 US Vascular Closure Device Market, by End Users
      • 11.1.2.7 Canada
        • 11.1.2.7.1 Overview
        • 11.1.2.7.2 Canada Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.2.7.3 Canada Vascular Closure Device Market, by Product Type
        • 11.1.2.7.3.1 Canada: Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
        • 11.1.2.7.3.2 Canada: Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
        • 11.1.2.7.4 Canada Vascular Closure Device Market, by Access
        • 11.1.2.7.5 Canada Vascular Closure Device Market, by Procedure
        • 11.1.2.7.6 Canada Vascular Closure Device Market, by End Users
      • 11.1.2.8 Mexico
        • 11.1.2.8.1 Overview
        • 11.1.2.8.2 Mexico Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.2.8.3 Mexico Vascular Closure Device Market, by Product Type
        • 11.1.2.8.3.1 Mexico: Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
        • 11.1.2.8.3.2 Mexico: Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
        • 11.1.2.8.4 Mexico Vascular Closure Device Market, by Access
        • 11.1.2.8.5 Mexico Vascular Closure Device Market, by Procedure
        • 11.1.2.8.6 Mexico Vascular Closure Device Market, by End Users
  • 11.2 Europe Vascular Closure Device Market, Revenue and Forecast to 2030
    • 11.2.1 Overview
    • 11.2.2 Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
      • 11.2.2.1 Europe Vascular Closure Device Market, by Product Type
        • 11.2.2.1.1 Europe: Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
        • 11.2.2.1.2 Europe: Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
      • 11.2.2.2 Europe Vascular Closure Device Market, by Access
      • 11.2.2.3 Europe Vascular Closure Device Market, by Procedure
      • 11.2.2.4 Europe Vascular Closure Device Market, by End Users
      • 11.2.2.5 Europe Vascular Closure Device Market by Country
      • 11.2.2.6 Germany
        • 11.2.2.6.1 Overview
        • 11.2.2.6.2 Germany Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.2.6.3 Germany Vascular Closure Device Market, by Product Type
        • 11.2.2.6.3.1 Germany: Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
        • 11.2.2.6.3.2 Germany: Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
        • 11.2.2.6.4 Germany Vascular Closure Device Market, by Access
        • 11.2.2.6.5 Germany Vascular Closure Device Market, by Procedure
        • 11.2.2.6.6 Germany Vascular Closure Device Market, by End Users
      • 11.2.2.7 UK
        • 11.2.2.7.1 Overview
        • 11.2.2.7.2 UK Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.2.7.3 UK Vascular Closure Device Market, by Product Type
        • 11.2.2.7.3.1 UK: Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
        • 11.2.2.7.3.2 UK: Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
        • 11.2.2.7.4 UK Vascular Closure Device Market, by Access
        • 11.2.2.7.5 UK Vascular Closure Device Market, by Procedure
        • 11.2.2.7.6 UK Vascular Closure Device Market, by End Users
      • 11.2.2.8 France
        • 11.2.2.8.1 Overview
        • 11.2.2.8.2 France Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.2.8.3 France Vascular Closure Device Market, by Product Type
        • 11.2.2.8.3.1 France: Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
        • 11.2.2.8.3.2 France: Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
        • 11.2.2.8.4 France Vascular Closure Device Market, by Access
        • 11.2.2.8.5 France Vascular Closure Device Market, by Procedure
        • 11.2.2.8.6 France Vascular Closure Device Market, by End Users
      • 11.2.2.9 Italy
        • 11.2.2.9.1 Overview
        • 11.2.2.9.2 Italy Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.2.9.3 Italy Vascular Closure Device Market, by Product Type
        • 11.2.2.9.3.1 Italy: Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
        • 11.2.2.9.3.2 Italy: Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
        • 11.2.2.9.4 Italy Vascular Closure Device Market, by Access
        • 11.2.2.9.5 Italy Vascular Closure Device Market, by Procedure
        • 11.2.2.9.6 Italy Vascular Closure Device Market, by End Users
      • 11.2.2.10 Spain
        • 11.2.2.10.1 Overview
        • 11.2.2.10.2 Spain Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.2.10.3 Spain Vascular Closure Device Market, by Product Type
        • 11.2.2.10.3.1 Spain: Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
        • 11.2.2.10.3.2 Spain: Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
        • 11.2.2.10.4 Spain Vascular Closure Device Market, by Access
        • 11.2.2.10.5 Spain Vascular Closure Device Market, by Procedure
        • 11.2.2.10.6 Spain Vascular Closure Device Market, by End Users
      • 11.2.2.11 Rest of Europe
        • 11.2.2.11.1 Overview
        • 11.2.2.11.2 Rest of Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.2.11.3 Rest of Europe Vascular Closure Device Market, by Product Type
        • 11.2.2.11.3.1 Rest of Europe: Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
        • 11.2.2.11.3.2 Rest of Europe: Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
        • 11.2.2.11.4 Rest of Europe Vascular Closure Device Market, by Access
        • 11.2.2.11.5 Rest of Europe Vascular Closure Device Market, by Procedure
        • 11.2.2.11.6 Rest of Europe Vascular Closure Device Market, by End Users
  • 11.3 Asia Pacific Vascular Closure Device Market, Revenue And Forecast to 2030
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
      • 11.3.2.1 Asia Pacific Vascular Closure Device Market, by Product Type
        • 11.3.2.1.1 Asia Pacific: Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
        • 11.3.2.1.2 Asia Pacific: Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
      • 11.3.2.2 Asia Pacific Vascular Closure Device Market, by Access
      • 11.3.2.3 Asia Pacific Vascular Closure Device Market, by Procedure
      • 11.3.2.4 Asia Pacific Vascular Closure Device Market, by End Users
      • 11.3.2.5 Asia Pacific Vascular Closure Device Market by Country
      • 11.3.2.6 China
        • 11.3.2.6.1 Overview
        • 11.3.2.6.2 China Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.2.6.3 China Vascular Closure Device Market, by Product Type
        • 11.3.2.6.3.1 China: Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
        • 11.3.2.6.3.2 China: Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
        • 11.3.2.6.4 China Vascular Closure Device Market, by Access
        • 11.3.2.6.5 China Vascular Closure Device Market, by Procedure
        • 11.3.2.6.6 China Vascular Closure Device Market, by End Users
      • 11.3.2.7 Japan
        • 11.3.2.7.1 Overview
        • 11.3.2.7.2 Japan Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.2.7.3 J
        • 11.3.2.7.4 apan Vascular Closure Device Market, by Product Type
        • 11.3.2.7.4.1 Japan: Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
        • 11.3.2.7.4.2 Japan: Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
        • 11.3.2.7.5 Japan Vascular Closure Device Market, by Access
        • 11.3.2.7.6 Japan Vascular Closure Device Market, by Procedure
        • 11.3.2.7.7 Japan Vascular Closure Device Market, by End Users
      • 11.3.2.8 India
        • 11.3.2.8.1 Overview
        • 11.3.2.8.2 India Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.2.8.3 India Vascular Closure Device Market, by Product Type
        • 11.3.2.8.3.1 India: Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
        • 11.3.2.8.3.2 India: Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
        • 11.3.2.8.4 India Vascular Closure Device Market, by Access
        • 11.3.2.8.5 India Vascular Closure Device Market, by Procedure
        • 11.3.2.8.6 India Vascular Closure Device Market, by End Users
      • 11.3.2.9 Australia
        • 11.3.2.9.1 Overview
        • 11.3.2.9.2 Australia Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.2.9.3 Australia Vascular Closure Device Market, by Product Type
        • 11.3.2.9.3.1 Australia: Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
        • 11.3.2.9.3.2 Australia: Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
        • 11.3.2.9.4 Australia Vascular Closure Device Market, by Access
        • 11.3.2.9.5 Australia Vascular Closure Device Market, by Procedure
        • 11.3.2.9.6 Australia Vascular Closure Device Market, by End Users
      • 11.3.2.10 South Korea
        • 11.3.2.10.1 Overview
        • 11.3.2.10.2 South Korea Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.2.10.3 South Korea Vascular Closure Device Market, by Product Type
        • 11.3.2.10.3.1 South Korea: Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
        • 11.3.2.10.3.2 South Korea: Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
        • 11.3.2.10.4 South Korea Vascular Closure Device Market, by Access
        • 11.3.2.10.5 South Korea Vascular Closure Device Market, by Procedure
        • 11.3.2.10.6 South Korea Vascular Closure Device Market, by End Users
      • 11.3.2.11 Rest of Asia Pacific
        • 11.3.2.11.1 Overview
        • 11.3.2.11.2 Rest of Asia Pacific Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.2.11.3 Rest of Asia Pacific Vascular Closure Device Market, by Product Type
        • 11.3.2.11.3.1 Rest of Asia Pacific: Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
        • 11.3.2.11.3.2 Rest of Asia Pacific: Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
        • 11.3.2.11.4 Rest of Asia Pacific Vascular Closure Device Market, by Access
        • 11.3.2.11.5 Rest of Asia Pacific Vascular Closure Device Market, by Procedure
        • 11.3.2.11.6 Rest of Asia Pacific Vascular Closure Device Market, by End Users
  • 11.4 Middle East & Africa Vascular Closure Device Market, Revenue And Forecast to 2030
    • 11.4.1 Overview
    • 11.4.2 Middle East & Africa Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
      • 11.4.2.1 Middle East & Africa Vascular Closure Device Market, by Product Type
        • 11.4.2.1.1 Middle East & Africa: Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
        • 11.4.2.1.2 Middle East & Africa: Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
      • 11.4.2.2 Middle East & Africa Vascular Closure Device Market, by Access
      • 11.4.2.3 Middle East & Africa Vascular Closure Device Market, by Procedure
      • 11.4.2.4 Middle East & Africa Vascular Closure Device Market, by End Users
      • 11.4.2.5 Middle East & Africa Vascular Closure Device Market by Country
      • 11.4.2.6 UAE
        • 11.4.2.6.1 Overview
        • 11.4.2.6.2 UAE Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.2.6.3 UAE Vascular Closure Device Market, by Product Type
        • 11.4.2.6.3.1 UAE: Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
        • 11.4.2.6.3.2 UAE: Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
        • 11.4.2.6.4 UAE Vascular Closure Device Market, by Access
        • 11.4.2.6.5 UAE Vascular Closure Device Market, by Procedure
        • 11.4.2.6.6 UAE Vascular Closure Device Market, by End Users
      • 11.4.2.7 Saudi Arabia
        • 11.4.2.7.1 Overview
        • 11.4.2.7.2 Saudi Arabia Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.2.7.3 Saudi Arabia Vascular Closure Device Market, by Product Type
        • 11.4.2.7.3.1 Saudi Arabia: Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
        • 11.4.2.7.3.2 Saudi Arabia: Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
        • 11.4.2.7.4 Saudi Arabia Vascular Closure Device Market, by Access
        • 11.4.2.7.5 Saudi Arabia Vascular Closure Device Market, by Procedure
        • 11.4.2.7.6 Saudi Arabia Vascular Closure Device Market, by End Users
      • 11.4.2.8 South Africa
        • 11.4.2.8.1 Overview
        • 11.4.2.8.2 South Africa Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.2.8.3 South Africa Vascular Closure Device Market, by Product Type
        • 11.4.2.8.3.1 South Africa: Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
        • 11.4.2.8.3.2 South Africa: Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
        • 11.4.2.8.4 South Africa Vascular Closure Device Market, by Access
        • 11.4.2.8.5 South Africa Vascular Closure Device Market, by Procedure
        • 11.4.2.8.6 South Africa Vascular Closure Device Market, by End Users
      • 11.4.2.9 Rest of Middle East & Africa
        • 11.4.2.9.1 Overview
        • 11.4.2.9.2 Rest of Middle East & Africa Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.2.9.3 Rest of Middle East & Africa Vascular Closure Device Market, by Product Type
        • 11.4.2.9.3.1 Rest of Middle East & Africa: Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
        • 11.4.2.9.3.2 Rest of Middle East & Africa: Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
        • 11.4.2.9.4 Rest of Middle East & Africa Vascular Closure Device Market, by Access
        • 11.4.2.9.5 Rest of Middle East & Africa Vascular Closure Device Market, by Procedure
        • 11.4.2.9.6 Rest of Middle East & Africa Vascular Closure Device Market, by End Users
  • 11.5 South & Central America Vascular Closure Device Market, Revenue And Forecast to 2030
    • 11.5.1 Overview
    • 11.5.2 South & Central America Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
      • 11.5.2.1 South & Central America Vascular Closure Device Market, by Product Type
        • 11.5.2.1.1 South & Central America: Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
        • 11.5.2.1.2 South & Central America: Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
      • 11.5.2.2 South & Central America Vascular Closure Device Market, by Access
      • 11.5.2.3 South & Central America Vascular Closure Device Market, by Procedure
      • 11.5.2.4 South & Central America Vascular Closure Device Market, by End Users
      • 11.5.2.5 South & Central America Vascular Closure Device Market by Country
      • 11.5.2.6 Brazil
        • 11.5.2.6.1 Overview
        • 11.5.2.6.2 Brazil Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.2.6.3 Brazil Vascular Closure Device Market, by Product Type
        • 11.5.2.6.3.1 Brazil: Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
        • 11.5.2.6.3.2 Brazil: Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
        • 11.5.2.6.4 Brazil Vascular Closure Device Market, by Access
        • 11.5.2.6.5 Brazil Vascular Closure Device Market, by Procedure
        • 11.5.2.6.6 Brazil Vascular Closure Device Market, by End Users
      • 11.5.2.7 Argentina
        • 11.5.2.7.1 Overview
        • 11.5.2.7.2 Argentina Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.2.7.3 Argentina Vascular Closure Device Market, by Product Type
        • 11.5.2.7.3.1 Argentina: Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
        • 11.5.2.7.3.2 Argentina: Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
        • 11.5.2.7.4 Argentina Vascular Closure Device Market, by Access
        • 11.5.2.7.5 Argentina Vascular Closure Device Market, by Procedure
        • 11.5.2.7.6 Argentina Vascular Closure Device Market, by End Users
      • 11.5.2.8 Rest of South & Central America
        • 11.5.2.8.1 Overview
        • 11.5.2.8.2 Rest of South & Central America Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.2.8.3 Rest of South & Central America Vascular Closure Device Market, by Product Type
        • 11.5.2.8.3.1 Rest of South & Central America: Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
        • 11.5.2.8.3.2 Rest of South & Central America: Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
        • 11.5.2.8.4 Rest of South & Central America Vascular Closure Device Market, by Access
        • 11.5.2.8.5 Rest of South & Central America Vascular Closure Device Market, by Procedure
        • 11.5.2.8.6 Rest of South & Central America Vascular Closure Device Market, by End Users

12. Vascular Closure Device Market Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Vascular Closure Devices Market
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Cordis Corp
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Transluminal Technologies LLC
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Vasorum Ltd
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Haemonetics Corp
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Abbott Laboratories
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Becton Dickinson and Co
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Cardinal Health Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 ENDOCOR GmbH & CO KG
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Medtronic Plc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Teleflex Inc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제